Psychedelic Therapy: A Primer for Primary Care Clinicians-N,N-Dimethyltryptamine and Ayahuasca: Erratum.
American Journal of Therapeutics November 1, 2024 DOI: 10.1097/mjt.0000000000001760 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Randomized Double-blind Open-label Peer reviewed |
|---|---|
| Topics | 5-MeO-DMT Ayahuasca DMT Psychedelic-assisted therapy |
| Key points | The claim of two double-blind randomized controlled trials on DMT is incorrect; none exist as of January 2024. |
Abstract
The first sentence in the Limitations section of the abstract for “Psychedelic Therapy: A Primer for Primary Care Clinicians - N,N-Dimethyltryptamine and Ayahuasca” stated:“There has only been a single published double-blind randomized controlled trial on ayahuasca and 2 on DMT.” The end of this sentence is incorrect. There are no published, double-blind randomized controlled trials on DMT as of January 2024, though there are top-line data and published open-label trials.1